-
公开(公告)号:US06743804B2
公开(公告)日:2004-06-01
申请号:US10140452
申请日:2002-05-07
IPC分类号: A62K3147
CPC分类号: C07D417/04 , A61K31/47 , A61K31/4709 , A61K31/473 , C07D215/52 , C07D221/18 , C07D401/04 , C07D401/12 , C07D405/04 , C07D409/04 , C07D409/12 , Y10S514/912
摘要: The present invention relates to a novel use, in particular a novel pharmaceutical use for a series of quinoline derivatives.
摘要翻译: 本发明涉及一系列喹啉衍生物的新用途,特别是新药用途。
-
公开(公告)号:US06608083B1
公开(公告)日:2003-08-19
申请号:US08450437
申请日:1995-05-25
IPC分类号: C07D21500
CPC分类号: C04B35/632 , A61K31/00 , A61K31/4709 , C07D215/52 , C07D221/18 , C07D401/04 , C07D401/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D417/04
摘要: NK3 receptor antagonists of formula (I): in which: Ar is an optionally substituted phenyl group, or a naphthyl or C5-7 cycloalkdienyl group, or an optionally substituted single or fused ring heterocyclic group, having aromatic character, containing from 5 to 12 ring atoms and comprising up to four hetero-atoms in the or each ring selected from S, O, N; R is linear or branched C1-8 alkyl, C3-7 cycloalkyl, C4-7 cycloalkylalkyl, an optionally substituted phenyl group or a phenyl C1-6 alkyl group, an optionally substituted five-membered heteroaromatic ring comprising up to four heteroatoms selected from O and N, hydroxy C1-6 alkyl, amino C1-6 alkyl, C1-6 alkylaminoalkyl, di C1-6 alkylaminoalkyl, C1-6 acylaminoalkyl, C1-6 alkoxyalkyl, C1-6 alkylcarbonyl, carboxy, C1-6 alkoxyxcarbonyl, C1-6 alkoxycarbonyl C1-6 alkyl, aminocarbonyl, C1-6 alkylaminocarbonyl, di C1-6 alkylaminocarbonyl, halogeno C1-6 alkyl; or is a group —(CH2)p— when cyclized onto Ar, where p is 2 or 3; R1 and R2, which may be the same or different, are independently hydrogen or C1-6 linear or branched alkyl, or together form a —(CH2)n— group in which n represents 3, 4, or 5; or R1 together with R forms a group —(CH2)q—, in which q is 2, 3, 4 or 5; R3 and R4, which may be the same or different are independently hydrogen, C1-6 linear or branched alkyl, C1-6 alkenyl, aryl, C1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulphonamido, C1-6 alkoxycarbonyl, trifluoromethyl, acyloxy, phthalimido, amino, mono- and di-C1-6 alkylamino, —O(CH2)r—NT2, in which r is 2, 3, or 4 and T is hydrogen or C1-6 alkyl or it forms with the adjacent nitrogen a group in which V and V1 are independently hydrogen or oxygen and u is 0,1 or 2; —O(CH2)s—OW2 in which s is 2, 3, or 4 and W is hydrogen or C1-6 alkyl; hydroxyalkyl, aminoalkyl, mono-or di-alkylaminoalkyl, acylamino, alkylsulphonylamino, aminoacylamino, mono- or di-alkylaminoacylamino; with up to four R3 substituents being present in the quinoline nucleus; or R4 is a group —(CH2)t— when cyclized onto R5 as aryl, in which t is 1, 2, or 3; R5 is branched or linear C1-6 alkyl, C3-7 cycloalkyl, C4-7 cycloalkylalkyl, optionally substituted aryl, wherein an optional substituent is hydroxy, halogen, C1-6 alkoxy or C1-6 alkyl, or an optionally substituted single or fused ring heterocyclic group, having aromatic character, containing from 5 to 12 ring atoms and comprising up to four hetero-atoms in the or each ring selected from S, O, N; in which inter alia, Ar is phenyl, optionally substituted by C1-6 alkyl or halogen; thienyl or a C5-7 cycloalkdienyl group; R is C1-6 alkyl, C1-6 alkoxycarbonyl, C1-6 alkylcarbonyl or hydroxy C1-6 alkyl; R1 and R2 are each hydrogen or C1-6 alkyl; R3 is hydrogen, hydroxy, halogen, C1-6 alkoxy or C1-6 alkyl; R4 is hydrogen, C1-6 alkyl, C1-6 alkoxy, hydroxy, anino, halogen, aminoalkoxy, mono- or di-alkylaminoalkoxy, mono- or di-alkylaminoalkyl, phthaloylalkoxy, mono- or di-alkylaminoacylarnino or acylamino; R5 is phenyl, thienyl, furyl, pyrryl or thiazolyl, and X is oxygen. X is O, S, or N—C≡N.
-
公开(公告)号:US06277862B1
公开(公告)日:2001-08-21
申请号:US09077151
申请日:1998-05-22
IPC分类号: A61K3147
CPC分类号: C07D215/52
摘要: A compound, or a solvate or a salt thereof, of formula (I), wherein, Ar is an optionally substituted aryl or a C5-7 cycloalkdienyl group, or an optionally substituted single or fused ring aromatic heterocyclic group; R, R1, R2 and R3 are as defined in the description; a process for the preparation of such a compound, a pharmaceutical composition containing such a compound or composition in medicine.
摘要翻译: 式(I)的化合物或其溶剂合物或其盐,其中Ar为任选取代的芳基或C 5-7环二烯基,或任选取代的单环或稠环芳族杂环基; R,R1,R2和R3如说明书中所定义; 制备这种化合物的方法,在药物中含有这种化合物或组合物的药物组合物。
-
公开(公告)号:US06969724B2
公开(公告)日:2005-11-29
申请号:US10324571
申请日:2002-12-19
申请人: Daniela Barlocco , Giorgio Cignarella , Giuseppe Arnaldo Maria Giardina , Mario Grugni , Silvano Ronzoni
发明人: Daniela Barlocco , Giorgio Cignarella , Giuseppe Arnaldo Maria Giardina , Mario Grugni , Silvano Ronzoni
IPC分类号: A61K31/451 , A61P1/16 , A61P5/00 , A61P9/00 , A61P9/04 , A61P9/10 , A61P11/00 , A61P13/02 , A61P15/10 , A61P25/00 , A61P25/04 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/28 , A61P43/00 , C07D211/14 , C07D211/18 , C07D211/22 , A61K31/445
CPC分类号: C07D211/18 , C07D211/14 , C07D211/22
摘要: Compounds of formula I, or a salt thereof or a hydrate thereof, as follows: wherein X and Y are selected independently from hydrogen and aryl, which aryl is unsubstituted or substituted one or more times by hydroxy, hydroxyC1-6alkyl, C1-6alkoxyC1-6alkyl, aryl, heterocyclyl, amino, C1-6alkylamino, di(C1-6alkyl)amino, arylC1-6alkoxy, C1-6alkyl, C1-6alkoxy or halo, which alkyl or alkoxy groups are unsubstituted or substituted one or more times by halo; m and n are independently 0 to 3, provided that m and n are not both 0; A represents a single bond or is —(CRpa Rpb)p— wherein p is 1-3 and Rpa and Rpb are selected independently from hydrogen, C1-6alkyl, C1-6alkoxy and halo, which alkyl or alkoxy groups are independently substituted one or more times by halo; B represents a C4-8 saturated or unsaturated ring, which ring is unsubstituted or substituted one or more times by C1-6alkyl, C1-6alkoxy, aryl, aryloxy, hydroxy, oxo, halo, amino, C1-6alkylamino, di(C1-6 alkyl)amino, and C1-6alkylamido, which C1-6alkyl or C1-6alkoxy groups are unsubstituted or substituted one or more times by halo, which aryl group is unsubstituted or substituted one or more times by aryl, heterocyclyl, aryloxy, arylC1-6alkoxy, amino, C1-6alkylamino, di(C1-6alkyl)amino, arylC1-6alkyl, hydroxy, C1-6alkenoxy, C1-6alkoxy, halo, or C1-6alkyl, which C1-6alkyl may be substituted one or more times by halo, and which aryl group is linked to said ring by a single bond or is benzo-condensed therewith are ligands of the ORL-1 receptor.
-
公开(公告)号:US06432977B1
公开(公告)日:2002-08-13
申请号:US09994076
申请日:2001-11-06
IPC分类号: A61K3147
CPC分类号: C07D215/52 , C07D215/50
摘要: A compound of formula (I) or a solvate thereof, characterized in that salt comprises a compound of formula (I) in anionic form and a salting cation; a process from preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
摘要翻译: 式(I)化合物或其溶剂合物,其特征在于盐包含阴离子形式的式(I)化合物和盐析阳离子; 制备这种化合物的方法,含有这种化合物的药物组合物和这种化合物在医药中的用途。
-
公开(公告)号:US5811553A
公开(公告)日:1998-09-22
申请号:US450438
申请日:1995-05-25
IPC分类号: A61K31/00 , A61K31/47 , A61K31/4709 , A61K31/473 , A61K45/00 , A61P1/00 , A61P1/14 , A61P1/16 , A61P3/00 , A61P3/04 , A61P11/00 , A61P11/02 , A61P11/06 , A61P13/00 , A61P13/02 , A61P13/12 , A61P17/00 , A61P17/06 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P27/00 , A61P27/02 , A61P27/16 , A61P29/00 , A61P37/08 , A61P43/00 , C07D215/52 , C07D221/18 , C07D401/04 , C07D401/12 , C07D405/04 , C07D405/12 , C07D409/04 , C07D409/12 , C07D417/04 , C07D215/20 , C07D215/14
CPC分类号: C04B35/632 , A61K31/00 , A61K31/4709 , C07D215/52 , C07D221/18 , C07D401/04 , C07D401/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D417/04
摘要: NK.sub.3 receptor antagonists of formula (I): ##STR1## are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders.
摘要翻译: 式(I)的NK3受体拮抗剂:(I)可用于治疗肺功能异常,CNS紊乱和神经变性疾病。
-
公开(公告)号:US20090005364A1
公开(公告)日:2009-01-01
申请号:US11794051
申请日:2005-12-22
申请人: Ilaria Peretto , Francesca Scarpitta , Elena La Porta , Luca Raveglia , Giuseppe Arnaldo Maria Giardina , Bruno Pietro Imbimbo , Andrea Rizzi , Gino Villetti
发明人: Ilaria Peretto , Francesca Scarpitta , Elena La Porta , Luca Raveglia , Giuseppe Arnaldo Maria Giardina , Bruno Pietro Imbimbo , Andrea Rizzi , Gino Villetti
IPC分类号: A61K31/55 , C07D401/04 , C07D403/04 , C07D401/14 , A61P1/00 , A61P11/00 , A61K31/4439 , A61K31/454
CPC分类号: C07D401/14 , C07D401/04
摘要: The present invention relates to compounds of formula (I) wherein R1, R2, x, X, Y and B are as defined in the description for the treatment of muscarinic acetylcholine receptor mediated diseases, in particular M3 muscarinic receptor mediated diseases.
摘要翻译: 本发明涉及式(I)化合物,其中R 1,R 2,X,X,Y和B如描述中所述,用于治疗毒蕈碱性乙酰胆碱受体介导的疾病,特别是M3毒蕈碱受体介导的疾病。
-
公开(公告)号:US07482458B2
公开(公告)日:2009-01-27
申请号:US11385461
申请日:2006-03-21
IPC分类号: C07D215/38 , C07D215/44 , A61K31/47
CPC分类号: C04B35/632 , A61K31/00 , A61K31/4709 , C07D215/52 , C07D221/18 , C07D401/04 , C07D401/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D417/04
摘要: NK3 receptor antagonists of formula (I): are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders.
摘要翻译: 式(I)的NK3受体拮抗剂:可用于治疗肺功能紊乱,中枢神经系统疾病和神经变性疾病。
-
公开(公告)号:US06355654B1
公开(公告)日:2002-03-12
申请号:US09077152
申请日:1998-05-21
IPC分类号: A61K3147
CPC分类号: C07D215/52 , C07D215/50
摘要: A compound of formula (I) or a solvate thereof, characterized in that salt comprises a compound of formula (I) in anionic form and a salting cation; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
摘要翻译: 式(I)化合物或其溶剂合物,其特征在于盐包含阴离子形式的式(I)化合物和盐析阳离子; 制备这种化合物的方法,含有这种化合物的药物组合物和这种化合物在医药中的用途。
-
-
-
-
-
-
-
-